KRAS and neoplasm: The differential enrichment of KRAS signaling between NMP and metastatic potency (MP) organoids may reflect that while KRAS activation is necessary for tumorigenesis, its role in metastasis could be modulated by other genetic or epigenetic factors present in the tumor microenvironment.